CH668005A5 - Fusogene liposome und verfahren zu deren herstellung. - Google Patents

Fusogene liposome und verfahren zu deren herstellung. Download PDF

Info

Publication number
CH668005A5
CH668005A5 CH1297/86A CH129786A CH668005A5 CH 668005 A5 CH668005 A5 CH 668005A5 CH 1297/86 A CH1297/86 A CH 1297/86A CH 129786 A CH129786 A CH 129786A CH 668005 A5 CH668005 A5 CH 668005A5
Authority
CH
Switzerland
Prior art keywords
ammonium hydroxide
liposomes
salt
liposome
cell
Prior art date
Application number
CH1297/86A
Other languages
German (de)
English (en)
Inventor
Adolfo Guillermo Gitman
Abraham Loyter
Original Assignee
Int Genetic Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Genetic Sciences filed Critical Int Genetic Sciences
Publication of CH668005A5 publication Critical patent/CH668005A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1297/86A 1985-04-04 1986-04-03 Fusogene liposome und verfahren zu deren herstellung. CH668005A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71986285A 1985-04-04 1985-04-04

Publications (1)

Publication Number Publication Date
CH668005A5 true CH668005A5 (de) 1988-11-30

Family

ID=24891665

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1297/86A CH668005A5 (de) 1985-04-04 1986-04-03 Fusogene liposome und verfahren zu deren herstellung.

Country Status (16)

Country Link
JP (1) JPS61274739A (fr)
AU (1) AU585330B2 (fr)
BE (1) BE904536A (fr)
BR (1) BR8601554A (fr)
CA (1) CA1262863A (fr)
CH (1) CH668005A5 (fr)
DE (1) DE3610873A1 (fr)
ES (1) ES8802401A1 (fr)
FR (1) FR2579891B1 (fr)
GB (1) GB2188900B (fr)
IL (1) IL78348A (fr)
IT (1) IT1189877B (fr)
NL (1) NL8600794A (fr)
NZ (1) NZ215696A (fr)
SE (1) SE464448B (fr)
ZA (1) ZA862466B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
JPS63275522A (ja) * 1987-05-01 1988-11-14 Terumo Corp 人工赤血球及びその製造方法
JPH04283207A (ja) * 1991-03-13 1992-10-08 Kao Corp ベシクル及び重合体ベシクル
JP4155601B2 (ja) * 1996-10-25 2008-09-24 モンサント・テクノロジー・エルエルシー 外因性化学物質で植物を処理するための組成物および方法
EP0941029B1 (fr) * 1996-10-25 2002-09-18 Monsanto Technology LLC Composition et procedes de traitement de plantes par des produits chimiques exogenes
WO2013039994A2 (fr) * 2011-09-12 2013-03-21 Cure Pharmaceutical Corp. Appareil, composition et procédés associés servant à administrer par voie transdermique des principes actifs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
AU594654B2 (en) * 1985-01-07 1990-03-15 Syntex (U.S.A.) Inc. 1,2 dialkoxy-omega-trialkylammonium cationic surfactants

Also Published As

Publication number Publication date
NZ215696A (en) 1989-07-27
SE464448B (sv) 1991-04-29
SE8601408D0 (sv) 1986-03-26
FR2579891A1 (fr) 1986-10-10
GB2188900A (en) 1987-10-14
SE8601408L (sv) 1986-10-05
GB8608468D0 (en) 1986-05-14
IL78348A (en) 1989-08-15
NL8600794A (nl) 1986-11-03
FR2579891B1 (fr) 1990-02-02
CA1262863A (fr) 1989-11-14
BR8601554A (pt) 1986-12-09
AU585330B2 (en) 1989-06-15
IT1189877B (it) 1988-02-10
ES8802401A1 (es) 1988-05-16
ES553703A0 (es) 1988-05-16
GB2188900B (en) 1990-04-04
BE904536A (fr) 1986-07-31
ZA862466B (en) 1986-11-26
IL78348A0 (en) 1986-07-31
JPS61274739A (ja) 1986-12-04
DE3610873A1 (de) 1986-10-09
AU5562286A (en) 1986-10-09
IT8683340A0 (it) 1986-04-03

Similar Documents

Publication Publication Date Title
DE68901955T2 (de) Insbesondere zum tragen von biologisch aktiven molekuelen geeignetes teilchenfoermiges vektorsystem und verfahren zu seiner herstellung.
DE69429186T2 (de) Liposomen, die materialien in partikelform enthalten
DE69535297T2 (de) Zubereitung multivesikulärer liposomen zur gesteuerten freisetzung von wirkstoffen
EP1363601B1 (fr) Liposomes amphoteres et leur utilisation
EP1131053B1 (fr) Nanocapsules et leur procede de production
DE69837339T2 (de) Veränderung der Wirkstoffladung in multivesikulären Liposomen
DE2946601C2 (de) Verfahren zum extemporierten Herstellen von Liposomen
DE69631149T2 (de) Formulierungen in form von emulsionen zur verabreichung von nukleinsäuren an zellen
DE69433532T2 (de) Amphiphile imidazolinium-derivate
DE69116144T2 (de) Bindung substratspezifischer affinitätssubstanzen an liposomen
DE3751871T2 (de) Guanidinaminoglycosid enthaltende Liposome
DE68919772T2 (de) Liposomen, an deren Oberfläche die Adsorption on Proteinen verhindert wird.
DE2907303A1 (de) Verfahren zur einkapselung biologisch aktiver substanzen
DE69906977T2 (de) In liposomen verkapselte nukleinsäurekomplexe
DE3650302T2 (de) Auf alpha-tocopherol basierte bläschen.
EP1289642B2 (fr) Nanocapsules a enveloppe de polyelectrolyte
DE69004329T2 (de) Verfahren zur Herstellung von antimikrobiellen Partikeln, antimikrobielle Mittel und Anwendungen.
DD210217A5 (de) Verfahren zur herstellung stabiler plurilamellarer blaeschen
DE69019640T2 (de) Verfahren zur herstellung von beta-1,3-glucan in algen.
DE2629100B2 (de) Dispersion von Kügelchen und Verfahren zu ihrer Herstellung
JPS61207324A (ja) リポソ−ム
CH668005A5 (de) Fusogene liposome und verfahren zu deren herstellung.
EP0883624B1 (fr) Tetraether lipides et liposomes les contenant, et utilisation de ceux-ci
DE3416978A1 (de) Durch liposom vermittelte transformation eukaryotischer zellen
DE69711907T2 (de) Mindestens eine nukleinsäure enthaltende zusammensetzungen

Legal Events

Date Code Title Description
PL Patent ceased